What is Jupiter Life Line Hospitals Ltd (JLHL) share price return in the past 10 years?

Data is not available for this company

What is the share price of Jupiter Life Line Hospitals Ltd (JLHL)?

Company share prices are keep on changing according to the market conditions. The current trading price of Jupiter Life Line Hospitals Ltd (JLHL) on 24-Jun-2026 16:59:59 at 16:59 is 1372.25.

What is the P/E ratio of Jupiter Life Line Hospitals?

The latest standalone P/E ratio of Jupiter Life Line Hospitals as of 24-Jun-2026 is 47.01.

What is the P/B ratio of Jupiter Life Line Hospitals Ltd (JLHL)?

The latest standalone P/B ratio of Jupiter Life Line Hospitals Ltd (JLHL) as of 24-Jun-2026 is 5.60.

What is the 52-week high and low of Jupiter Life Line Hospitals Ltd (JLHL)?

The 52-week high of Jupiter Life Line Hospitals Ltd (JLHL) is Rs. 1618.15 and the 52-week low is Rs. 1152.05.

Jupiter Life Line Hospitals Ltd (JLHL) Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: Jupiter Life Line Hospitals Ltd (JLHL)
Brand: Jupiter Life Line Hospitals

Key Metrics

Valuation Multiples

Market Cap

₹8,997 Cr.

Current Price

₹1,372.3

52-Week Low / High

₹1,152 / 1,618

TTM EPS

₹29.2

TTM Sales

₹1,198 Cr.

Book Value per Share

₹245.2

P/E Ratio

47.01

Lower than its 5-year historical median

Industry PE

91.4

Price to Book (P/B)

5.60

Lower than its 5-year historical median

Price to Sales (P/S)

7.51

Lower than its 5-year historical median

EV/EBITDA

26.92

Lower than its 5-year historical median

Dividend Yield

0.07%

Profitability Efficiency

Return on Equity (ROE)

12.63%

Underperforms industry median

Return on Capital Employed (ROCE)

16.00%

Underperforms industry median

Return on Assets (ROA)

9.87%

Operating Profit Margin

25.1%

Net Profit Margin

15.98%

Gross Profit Margin

27.5%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Slowing versus 3-year growth rate

12.98%

Operating Profit Growth (1 Year)

Slowing versus 3-year growth rate

10.77%

Net Profit Growth (1 Year)

Slowing versus 3-year growth rate

3.62%

Asset Quality

Promoter Holding

40.91%

Pledged shares (%) of Promoter's holding (%)

0.00%

Reserves

₹1,542 Cr.

Equity

₹65.6 Cr.

Face Value

₹10

All Time Low / High

₹960.00 / 1759.00

Jupiter Life Line Hospitals stock performance

Key Ratios

Check Before You Invest

Quality

Locked

Valuation

Locked

Price Trend

Locked

Q.1 Is Jupiter Life Line Hospitals Ltd a good quality company?

Jupiter Life Line Hospitals Ltd is a good quality company, based on a consistently good multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.

How does Jupiter Life Line Hospitals Ltd performance compare with that of its Peers?

Q.1 Revenue growth of Jupiter Life Line Hospitals Ltd vs industry peers?

Jupiter Life Line Hospitals Ltd revenue CAGR is 18.02%, compared to the industry median CAGR of 1.38%, indicating faster growth and gaining its market share.

Q.1 Promoter shareholding and pledge status of Jupiter Life Line Hospitals Ltd?

Promoters hold 40.91% of the Jupiter Life Line Hospitals Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Stock return of Jupiter Life Line Hospitals Ltd over the last decade?

Over the last 1 year(s), the stock has delivered a CAGR of -8.17% based on the current price.

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	Mar'26	TTM
ROCE % ⓘ	17.2%	10.4%	10%	12.1%	9%	23.2%	26.4%	22.2%	18.6%	16%	-
Value Creation Index ⓘ	0.3	-0.2	-0.3	-0.1	-0.3	0.7	1.0	0.6	0.4	0.2	-
Growth Parameters ⓘ
Sales ⓘ	264	320	399	463	461	657	787	915	1,060	1,198	1,198
Sales YoY Gr.	-	21.3%	24.4%	16.2%	-0.4%	42.6%	19.8%	16.2%	15.9%	13%	-
Adj EPS ⓘ	5.8	5.9	3.6	5.8	3.3	16.6	19.2	23.2	28	28.5	29.2
YoY Gr.	-	1.6%	-39.5%	63.5%	-44%	409.2%	15.7%	20.7%	20.6%	1.8%	-
BVPS (₹) ⓘ	33.7	39	41.9	46.5	49.8	64.3	82.3	189.9	217	245.2	245.2
Adj Net Profit ⓘ	29.3	29.9	18.1	29.6	16.6	84.5	109	152	183	187	191
Cash Flow from Ops. ⓘ	62.7	43.5	45.6	74.6	113	142	184	110	219	231	-
Debt/CF from Ops. ⓘ	3	4.8	5.5	3.5	2.3	2.3	1.6	0	0.3	1.1	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	18.3%	21%	15%	13%
Adj EPS ⓘ	19.4%	54.3%	14%	1.8%
BVPSⓘ	24.7%	37.6%	43.9%	13%
Share Price	-	-	-	-3.9%

Key Financial Parameters ⓘ

	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	Mar'26	TTM
Return on Equity % ⓘ	18.9	16.2	8.8	13.2	6.8	29	27.4	17.8	13.8	12.3	11.9
Op. Profit Mgn % ⓘ	23.3	17	16.3	17.6	14.6	24.2	25.9	24.9	25.7	25.1	25.1
Net Profit Mgn % ⓘ	11.1	9.3	4.5	6.4	3.6	12.9	13.8	16.6	17.3	15.6	16
Debt to Equity ⓘ	1.1	1.1	1.2	1.1	1	1	0.6	0	0.1	0.2	0.2
Working Cap Days ⓘ	50	54	65	88	91	54	62	115	97	69	97
Cash Conv. Cycle ⓘ	-42	-41	-28	-29	-36	-35	-32	-23	-15	-14	74

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	Mar'26
Sales	264	320	399	463	461	657	787	915	1,060	1,198
Operating Expenses ⓘ +	203	266	334	382	394	498	583	687	791	899
Manufacturing Costs	17	23	51	61	56	67	89	95	121	141
Material Costs	50	60	81	80	94	127	135	159	191	213
Employee Cost	43	67	82	93	100	114	129	159	177	196
Other Costs ⓘ	93	116	120	148	143	190	230	275	301	349
Operating Profit ⓘ	62	54	65	81	68	159	204	227	269	298
Operating Profit Margin (%)	23.3%	17.0%	16.3%	17.6%	14.6%	24.2%	25.9%	24.9%	25.4%	24.9%
Other Income ⓘ +	3	5	3	3	6	4	13	26	28	44
Exceptional Items ⓘ	0	0	0	0	0	0	-2	0	0	-4
Interest ⓘ	8	16	24	26	28	29	28	19	9	13
Depreciation ⓘ	12	20	24	26	27	28	29	31	42	69
Profit Before Tax ⓘ	45	24	20	33	18	106	159	204	246	257
Tax ⓘ	15	-6	2	3	1	21	52	52	62	65
Profit After Tax	29	30	18	30	17	85	107	152	185	191
PAT Margin (%)	11.1%	9.3%	4.6%	6.4%	3.6%	12.9%	13.6%	16.6%	17.4%	16.0%
Adjusted EPS (₹)	5.8	5.9	3.6	5.8	3.3	16.7	19.0	23.2	28.2	29.2
Dividend Payout Ratio (%)	8.60%	8.50%	28%	0%	0%	6%	5.30%	4.30%	3.60%	3.40%

Valuation of Jupiter Life Line - Standalone

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	Mar'26
Equity and Liabilities
Shareholders Fund +	170	198	213	237	253	327	465	1,245	1,423	1,608
Share Capital ⓘ	51	51	51	51	51	51	57	66	66	66
Reserves ⓘ	120	147	162	186	202	276	409	1,180	1,357	1,542
Debt +	180	197	241	254	250	319	295	0	74	258
Long Term Debt	177	186	234	244	258	298	295	0	74	258
Short Term Debt	3	11	7	10	-9	21	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	28	37	37	59	50	54	62	51	54	73
Others Liabilities ⓘ	41	38	45	44	63	55	63	65	167	222
Total Liabilities ⓘ	420	470	537	594	615	755	885	1,361	1,718	2,160
Fixed Assets
Net Fixed Assets ⓘ +	246	379	431	435	426	465	476	477	713	1,123
Gross Block	319	471	547	576	595	660	700	731	977	1,453
Accumulated Depreciation	73	93	116	141	168	195	224	254	264	330
CWIP ⓘ	132	28	12	11	13	14	16	61	163	113
Investments ⓘ	1	1	2	2	65	71	95	111	606	580
Inventories	6	10	10	14	12	13	15	17	18	29
Trade Receivables	13	18	26	45	20	28	40	46	38	67
Cash Equivalents	3	4	8	7	19	102	133	297	87	41
Others Assets ⓘ	17	31	48	81	59	62	108	351	93	208
Total Assets ⓘ	420	470	537	594	615	755	885	1,361	1,718	2,160

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	Mar'26
Cash Flow From Operating Activity ⓘ +	63	43	46	75	113	142	184	110	219	231
PBT ⓘ	45	24	20	33	18	106	159	204	246	261
Adjustment ⓘ	18	31	45	66	54	54	49	25	26	46
Changes in Working Capital ⓘ	9	-0	-5	-9	51	-9	10	-69	9	-17
Tax Paid ⓘ	-9	-11	-14	-15	-10	-9	-33	-50	-62	-59
Cash Flow From Investing Activity ⓘ +	-133	-43	-58	-43	-78	-69	-130	-238	-455	-423
Capex	-135	-48	-60	-29	-22	-66	-43	-76	-280	-483
Net Investments	-0	-0	1	0	-57	-5	-34	-185	-197	30
Others ⓘ	2	5	1	-15	1	2	-52	23	23	29
Cash Flow From Financing Activity ⓘ +	68	1	16	-32	-23	10	-23	122	302	145
Net Proceeds from Shares ⓘ	2	1	0	0	0	2	34	633	0	0
Net Proceeds from Borrowing ⓘ	0	0	47	7	18	31	-3	-295	75	186
Interest Paid ⓘ	-8	-16	-24	-26	-28	-29	-28	-19	-6	-5
Dividend Paid ⓘ	-3	-3	-3	-5	0	0	-5	-6	-7	-7
Others ⓘ	77	18	-4	-9	-13	7	-21	-192	239	-29
Net Cash Flow ⓘ	-3	1	3	-1	12	84	31	-6	66	-47

Financial Ratio

PARTICULARS	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	Mar'26
Ratios
ROE (%)	18.89	16.23	8.82	13.17	6.77	29.18	27.07	17.77	13.85	12.63
ROCE (%)	17.19	10.42	9.95	12.14	9.01	23.15	26.4	22.16	18.59	16
Asset Turnover Ratio	0.74	0.72	0.79	0.82	0.76	0.96	0.96	0.81	0.69	0.62
PAT to CFO Conversion(x)	2.17	1.43	2.56	2.5	6.65	1.67	1.72	0.72	1.18	1.21
Working Capital Days
Receivable Days	17.40	17.70	19.90	27.80	25.70	13.40	15.70	17.20	14.50	16
Inventory Days	8.20	9.30	9.20	9.50	10.10	6.90	6.70	6.40	6	7.10
Payable Days	167.40	196.10	167	219.20	209.60	148.90	157	129.90	100	108.50

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Jupiter Life Line Hospitals Ltd FAQs

The current trading price of Jupiter Life Line on 24-Jun-2026 16:59 is ₹1,372.3.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 23-Jun-2026 the market cap of Jupiter Life Line stood at ₹8,997.3 Cr

The latest P/E ratio of Jupiter Life Line as of 23-Jun-2026 is 47.01.

The latest P/B ratio of Jupiter Life Line as of 23-Jun-2026 is 5.60.

The 52-week high of Jupiter Life Line is ₹1,618.2 and the 52-week low is ₹1,152.1.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Jupiter Life Line is ₹1,198 ( Cr.) .

Past 10 year's financial track record analysis by Moneyworks4me indicates that Jupiter Life Line Hospitals Ltd is a good quality company.

The key valuation ratios of Jupiter Life Line Hospitals Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Jupiter Life Line Hospitals Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.

About Jupiter Life Line Hospitals Ltd

Jupiter Life Line Hospitals was incorporated in Mumbai, Maharashtra, as ‘Jupiter Life Line Hospitals Limited’, a public limited company under the Companies Act, 1956, pursuant to a certificate of incorporation dated November 18, 2002, issued by the RoC. The company commenced its business on December 24, 2002. The company is among the key multi-specialty tertiary and quaternary healthcare providers in the Mumbai Metropolitan Area (MMR) and western region of India. It has been operating for many years as a corporate quaternary care healthcare service provider in densely populated micro markets in the western regions of India and currently operate three hospitals under the ‘Jupiter’ brand in Thane, Pune and Indore. It is also currently in the process of developing a multi-specialty hospital in Dombivli, Maharashtra, which is designed to accommodate many beds.

The company commenced operations in 2007 with its hospital in Thane, Maharashtra and subsequently scaled its operations by setting up a hospital in Pune, Maharashtra in 2017 and acquiring a hospital in Indore, Madhya Pradesh in 2020. Its hospitals are also located in densely populated micro markets which have a low presence of chained hospitals, which provides it an opportunity to offer its services to a larger population and helps its patients with greater access and connectivity to healthcare services. Its hospitals function on an ‘all-hub-no-spoke’ model with each hospital being a full-service hospital, operating independently and serving the healthcare needs of patients, right from diagnostics to surgery and rehabilitation. Its Thane and Pune hospitals are ‘greenfield’ projects, and all three of its hospitals are located on land owned by it on a freehold basis, which ensures operational control and allows it consistency in quality care resulting in long-term operational and financial efficiencies.

Business area of the company

The company is engaged in the business of operating and managing hospitals and clinics in India. The company is among the key multi-specialty tertiary and quaternary healthcare providers.

Awards

2018: Awarded the Best Multispecialty hospital in Thane District at the NavBharat Healthcare Excellence Awards.
2019: Awarded the Hospital of the year - India at the Healthcare Asia Awards.
2019: Awarded for outstanding contribution in charitable healthcare at the Star of the Industry Awards.
2019: Received the award for best design in healthcare for its Indore Hospital, at the Healthcare Leadership Awards.
2021: Recognized for excellence in change management for its Thane Hospital at the CHRO Vision & Innovation Summit and Awards.
2021: Winner of the award for excellence in workplace management for the human resources department of its Thane Hospital at the CHRO Vision & Innovation Summit and Awards.
2021: Received the Silver award - Covid Protection Project at the IHW Awards.
2022: Received the NEERMAN award in the healthcare category for its Pune Hospital.
2022: Received the milestone merits 2022 - safety award from the IMC Ramkrishna Bajaj National Quality Trust.
2023: Awarded the certificate of excellence for its Indore Hospital for being the cleanest hospital in Indore at the Swachh Ward Rankings.
2023: Awarded the Maharashtra state best employer brand award, 2023 at the 18th Employer Branding Awards.

Accreditations and recognitions

2020: Accreditation for its Thane Hospital by the National Accreditation Board for Hospital & Healthcare Providers.
2020: Accreditation for its Pune Hospital, Maharashtra by the National Accreditation Board for Hospital & Healthcare Providers.
2021: Accreditation for its Indore Hospital, Madhya Pradesh by the National Accreditation Board for Hospital & Healthcare Providers.
2022: ISO 15189:2012 accreditation for the department of laboratory medicine of its Pune Hospital by the National Accreditation Board for Testing and Calibration Laboratories.
2022: ISO 15189:2012 accreditation for the department of laboratory medicine of its Thane Hospital by the National Accreditation Board for Testing and Calibration Laboratories.
2023: ISO 22000:2018 accreditation for food safety and management system for the Fortune Park Lake City hotel at Thane by the Standards Council of Canada.

History and milestones

2007: Established and commenced operations of its first hospital at Thane, Maharashtra.
2017: Established and commenced operations of its Pune Hospital.
2018: Carried out interstitial brachytherapy to treat cancer at its Thane Hospital.
2020: Acquired its Indore Hospital.
2021: Successfully carried out small bowel intestine transplant surgery at its Thane, Hospital.
2022: Successfully carried out heart transplant surgery at its Thane Hospital.

Jupiter Life Line Hospitals Ltd (JLHL)

Jupiter Life Line Hospitals Ltd (JLHL)

Jupiter Life Line Hospitals stock performance

Check Before You Invest

Quality

Valuation

Price Trend

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Jupiter Life Line - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Jupiter Life Line Hospitals Ltd FAQs

About Jupiter Life Line Hospitals Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Jupiter Life Line Hospitals Ltd (JLHL)

Jupiter Life Line Hospitals Ltd (JLHL)

Jupiter Life Line Hospitals stock performance

Check Before You Invest

Quality

Valuation

Price Trend

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Jupiter Life Line - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Jupiter Life Line Hospitals Ltd FAQs

What is the share price of Jupiter Life Line?

What is the market cap of Jupiter Life Line?

What is the P/E ratio of Jupiter Life Line?

What is the P/B ratio of Jupiter Life Line?

What is the 52-week high and low of Jupiter Life Line?

What is the TTM revenue of Jupiter Life Line?

Is Jupiter Life Line Hospitals Ltd a good quality company?

Is Jupiter Life Line Hospitals Ltd undervalued or overvalued?

Is Jupiter Life Line Hospitals Ltd a good buy now?

About Jupiter Life Line Hospitals Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.